Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1987-04-09
1988-06-28
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
A61K 31135
Patent
active
047539658
ABSTRACT:
Certain chalcone derivatives are reported to inhibit the polymerization of tubulin to form microtubules and are therefore antimitotic agents which can be used to control the growth of tumor tissue and can be used as antigout agents.
REFERENCES:
patent: 3729313 (1973-04-01), Smith
patent: 3808006 (1974-04-01), Smith
patent: 4054682 (1977-10-01), Kuesters et al.
patent: 4162162 (1979-07-01), Dueber
patent: 4279930 (1982-07-01), Hall et al.
patent: 4290870 (1981-09-01), Kondoh et al.
patent: 4367280 (1983-01-01), Kondo et al.
Chem. Abst. 83/170.626 u (1975).
Chemical Abstract 62:14039, V. F. Lavrushin, V. P. Dzyuba and V. N. Tomachev. Zh. Obshch. Chim. 35(1), 95-103 (1965).
Chemical Abstract 60:443, V. F. Lavrushin and V. P. Dzyuba, Zh. Obsch. Khim. 33(8), 2581-2585, (1963).
Chemical Abstract 66:6820, V. F. Lavrushin, V. P. Dzyuba and V. N. Tolmachev. Zh. Obshch. Khim. 36(8), 1374-1380, (1966).
Edwards Michael L.
Stemerick David M.
Sunkara Sai P.
Dixon J. Michael
Friedman Stanley J.
Merrell Dow Pharmaceuticals Inc.
LandOfFree
Method of treating multiple sclerosis with chalcone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating multiple sclerosis with chalcone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating multiple sclerosis with chalcone derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1914992